or suspensions can also contain a long chain alcohol diluent or dispersant or carboxymethyl cellulose or similar dispersing agents a carrier in a pharmaceutical composition must be u201c acceptable u201d in the sense of being compatible with the active ingredient of the formulation and preferably capable of stabilizing it and not deleterious to the subject to be treated for example solubilizing agents such as cyclodextrins which form specific more soluble complexes with the fused pyrazolyl compound or one or more solubilizing agents can be utilized as pharmaceutical excipients for delivery of the fused pyrazolyl compound examples of other carriers include colloidal silicon dioxide magnesium stearate cellulose sodium lauryl sulfate and d amp c yellow 10 in vivo screening can be performed by following procedures well known in the art see the specific examples below without further elaboration it is believed that the above description has adequately enabled the present invention the following specific embodiments are therefore to be construed as merely illustrative and not limitative of the remainder of the disclosure in any way whatsoever all of the publications including patents cited herein are hereby incorporated by reference in their entirety calcium borohydride was first prepared by stirring anhydrous calcium chloride 88 8 mg 0 8 mmole with sodium borohydride 60 mg 1 6 mmole in anhydrous thf 20 ml for 4 hrs a 30 ml thf solution containing 88 0 mg 1 benzyl.